261 related articles for article (PubMed ID: 20923428)
21. Attention-deficit/hyperactivity disorder: use of cognitive evoked potential (P300) to predict treatment response.
Sangal RB; Sangal JM
Clin Neurophysiol; 2006 Sep; 117(9):1996-2006. PubMed ID: 16890481
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data.
Sonuga-Barke EJ; Swanson JM; Coghill D; DeCory HH; Hatch SJ
BMC Psychiatry; 2004 Sep; 4():28. PubMed ID: 15458569
[TBL] [Abstract][Full Text] [Related]
23. [The diagnostic evaluation and therapeutic basis of immediate release methylphenidate in attention deficit hyperactivity disorder].
Valdizán JR
Rev Neurol; 2004 Mar 16-31; 38(6):501-6. PubMed ID: 15054710
[TBL] [Abstract][Full Text] [Related]
24. Tolerability and effects of OROS® MPH (Concerta ®) on functioning, severity of disease and quality of life in children and adolescents with ADHD: results from a prospective, non-interventional trial.
Gerwe M; Stollhoff K; Mossakowski J; Kuehle HJ; Goertz U; Schaefer C; Bogdanow M; Heger S
Atten Defic Hyperact Disord; 2009 Dec; 1(2):175-86. PubMed ID: 21432582
[TBL] [Abstract][Full Text] [Related]
25. [The value of cognitive evoked potentials in assessing the effectiveness of methylphenidate treatment in children with attention deficit hyperactivity disorder].
Idiazábal-Alecha MA; Rodríguez-Vázquez S; Guerrero-Gallo D; Vicent-Sardinero X
Rev Neurol; 2005 Jan; 40 Suppl 1():S37-42. PubMed ID: 15736091
[TBL] [Abstract][Full Text] [Related]
26. Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder.
Huang YS; Chao CC; Wu YY; Chen YY; Chen CK
Psychiatry Clin Neurosci; 2007 Jun; 61(3):219-25. PubMed ID: 17472588
[TBL] [Abstract][Full Text] [Related]
27. Neurocognitive effects of switching from methylphenidate-IR to OROS-methylphenidate in children with ADHD.
Kim Y; Shin MS; Kim JW; Yoo HJ; Cho SC; Kim BN
Hum Psychopharmacol; 2009 Mar; 24(2):95-102. PubMed ID: 19226534
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
Golubchik P; Sever J; Weizman A
Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
[TBL] [Abstract][Full Text] [Related]
29. Event-related wave activity in the EEG provides new marker of ADHD.
Alexander DM; Hermens DF; Keage HA; Clark CR; Williams LM; Kohn MR; Clarke SD; Lamb C; Gordon E
Clin Neurophysiol; 2008 Jan; 119(1):163-79. PubMed ID: 18054279
[TBL] [Abstract][Full Text] [Related]
30. Norepinephrine transporter -3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment.
Cho SC; Kim BN; Cummins TD; Kim JW; Bellgrove MA
J Psychopharmacol; 2012 Mar; 26(3):380-9. PubMed ID: 21628343
[TBL] [Abstract][Full Text] [Related]
31. Time course of treatment effect of OROS® methylphenidate in children with ADHD.
Armstrong RB; Damaraju CV; Ascher S; Schwarzman L; O'Neill J; Starr HL
J Atten Disord; 2012 Nov; 16(8):697-705. PubMed ID: 22084448
[TBL] [Abstract][Full Text] [Related]
32. Transitioning to OROS(®) methylphenidate from atomoxetine is effective in children and adolescents with ADHD.
Niederkirchner K; Slawik L; Wermelskirchen D; Rettig K; Schäuble B
Expert Rev Neurother; 2011 Apr; 11(4):499-508. PubMed ID: 21469923
[TBL] [Abstract][Full Text] [Related]
33. Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) topography predicts treatment response to methylphenidate.
Sangal RB; Sangal JM
Clin Neurophysiol; 2004 Jan; 115(1):188-93. PubMed ID: 14706487
[TBL] [Abstract][Full Text] [Related]
34. Effects of MPH-OROS on the organizational, time management, and planning behaviors of children with ADHD.
Abikoff H; Nissley-Tsiopinis J; Gallagher R; Zambenedetti M; Seyffert M; Boorady R; McCarthy J
J Am Acad Child Adolesc Psychiatry; 2009 Feb; 48(2):166-75. PubMed ID: 19127171
[TBL] [Abstract][Full Text] [Related]
35. Naturalistic exploration of the effect of osmotic release oral system-methylphenidate on remission rate and functional improvement in Taiwanese children with attention-deficit-hyperactivity disorder.
Tzang RF; Wang YC; Yeh CB; Hsu CD; Liang HY; Yang PC; Liu HJ; Huang YS; Cheng H; Hsu YC; Liu SI; Pan CH; Huang YF; Huang CF; Wu YY; Huang YH; Liu HC; Chang HL
Psychiatry Clin Neurosci; 2012 Feb; 66(1):53-63. PubMed ID: 22250610
[TBL] [Abstract][Full Text] [Related]
36. OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.
Ramos-Quiroga JA; Corominas M; Castells X; Bosch R; Casas M
Expert Rev Neurother; 2009 Aug; 9(8):1121-31. PubMed ID: 19673602
[TBL] [Abstract][Full Text] [Related]
37. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
[TBL] [Abstract][Full Text] [Related]
38. A randomized, double-blind study of 30 versus 20 mg dexmethylphenidate extended-release in children with attention-deficit/hyperactivity disorder: late-day symptom control.
Brams M; Turnbow J; Pestreich L; Giblin J; Childress A; McCague K; Muniz R
J Clin Psychopharmacol; 2012 Oct; 32(5):637-44. PubMed ID: 22926597
[TBL] [Abstract][Full Text] [Related]
39. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
[TBL] [Abstract][Full Text] [Related]
40. Dissociation in response to methylphenidate on response variability in a group of medication naïve children with ADHD.
Johnson KA; Barry E; Bellgrove MA; Cox M; Kelly SP; Dáibhis A; Daly M; Keavey M; Watchorn A; Fitzgerald M; McNicholas F; Kirley A; Robertson IH; Gill M
Neuropsychologia; 2008 Apr; 46(5):1532-41. PubMed ID: 18289615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
